Genetic diversity of HIV-1 in western Kenya: Subtype-specific differences in mother-to-child transmission

AIDS

Volumn 17, Issue 11, 2003, Pages 1667-1674

  Yang, Chunfu ^a   Li, Ming ^a   Newman, Robert D ^a,b   Shi, Ya Ping ^b,c   Ayisi, John ^c   Van Eijk, Anna M ^c   Otieno, Juliana ^d   Misore, Ambrose O ^d   Steketee, Richard W ^b   Nahlen, Bernard L ^b,e   Lal, Renu B ^a,f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d New Nyanza Provincial General Hospital   (Kenya)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f Immunology Branch   (United States)

Author keywords

HIV 1 subtypes; Risk factors for HIV 1 transmission; Subtype specific differences; Vertical transmission of HIV 1

Indexed keywords

ANTIGEN P24; GAG PROTEIN; GLYCOPROTEIN GP 41;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISIOTOMY; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; KENYA; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; PERINEUM INJURY; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPECIES COMPARISON; VERTICAL TRANSMISSION; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; KENYA; LOGISTIC MODELS; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; VIRAL LOAD;

EID: 0043129073     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200307250-00011     Document Type: Article

References (43)

1. McCutchan FE. Understanding the genetic diversity of HIV-1. AIDS 2000; 14:S31-S44.
2. Peeters M, Sharp PM. The genetic diversity of HIV-1: the moving target. AIDS 2000; 14:S129-S140.
3. Hu DJ, Buve A, Baggs J, van der Groen G, Dondero TJ. What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. AIDS 1999; 13:873-881.
4. Kuiken C, Thakallapalli R, Esklid A, de Ronde A. Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus. Am J Epidemiol 2000; 152:814-822.
5. Essex M. Human immunodeficiency viruses in the developing world. Adv Virus Res 1999; 53:71-88.
6. Alaeus A. Significance of HIV-1 genetic subtypes. Scand J Infect Dis 2000; 32:455-463.
7. Hu DJ, Vanichseni S, Mastro TD, Raktham S, Young NL, Mock PA, et al. Viral load differences in early infection with two HIV-1 subtypes. AIDS 2001; 15:683-691.
8. Neilson JR, John GC, Carr JK, Lewis P, Kreiss JK, Jackson S, et al. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999; 73:4393-4403.
9. Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng H, Littman DR, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998; 241:181-188.
10. Bjorndal A, Sonnerborg A, Tscherning C, Albert J, Fenyo EM. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retroviruses 1999; 15:647-653.
11. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 2000; 74:3740-3751.
12. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179:68-73.
13. Alaeus A, Lidman K, Bjorkman A, Giesecke J, Albert J. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS 1999; 13:901-907.
14. Amornkul PN, Tansuphasawadikul S, Limpakarnjanarat K, Likanonsakul S, Young N, Eampokalap B, et al. Clinical disease associated with HIV-1 subtype B' and E infection among 2104 patients in Thailand. AIDS 1999; 13:1963-1969.
15. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002; 185:1244-1250.
16. Blackard JT, Renjifo B, Fawzi W, Hertzmark E, Msamanga G, Mwakagile D, et al. HIV-1 LTR subtype and perinatal transmission. Virology 2001; 287:261-265.
17. Renjifo B, Fawzi W, Mwakagile D, Hunter D, Msamanga G, Spiegelman D, et al. Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes. J Hum Virol 2001; 4:16-25.
18. Murray MCM, Embree JE, Ramdahin SG, Anzala AO, Njenga S, Plummer FA. Effect of human immunodeficiency virus (HIV) type 1 viral genotype on mother-to-child transmission of HIV-1. J Infect Dis 2000; 181:746-749.
19. Shaffer N, Roongpisuthipong A, Siriwasin W, Chotpitayasunondh T, Chearskul S, Young NL, et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis 1999; 179:590-599.
20. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1. Nature 1995; 374:124-126.
21. Overbaugh J, Bangham CR. Selection forces and constraints on retroviral sequence variation. Science 2001; 292:1106-1109.
22. Quinones-Mateu ME, Arts EJ. Recombination in HIV-1: update and implications. AIDS Review 1999; 1:89-100.
23. Peeters M. Recombinant HIV sequences: their role in the global epidemic. In: HIV sequence compendium. Kuiken C, Foley B, Hahn B, et al. (editors). Los Alamos, NM: Los Alamos National Laboratory, Theoretical Biology and Biophysics Group; 2000. pp. 54-72.
24. Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, Dougherty JP. High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol 2000; 74:1234-1240.
25. Blackard JT, Cohen DE, Mayer KH. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clin Infect Dis 2002; 34:1108-1114.
26. Moutouh U Corbeil J, Richman DD. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci USA 1996; 93:6106-6111.
27. Bulterys M, Nolan ML, Jamieson DJ, Dominguez K, Fowler MG. Advances in the prevention of mother-to-child HIV-1 transmission: current issues, future challenges. AIDS Science 2002; 2:1-17.
28. Kampinga GA, Simonon A, Van de Perre P, Karita E, Msellati P, Goudsmit J. Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology 1997; 227:63-76.
29. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996; 271:1291-1293.
30. Pope M, Ho DD, Moore JP, Weber J, Dittmar MT, Weiss RA. Different subtypes of HIV-1 and cutaneous dendritic cells. Science 1997; 278:786-788.
31. Ayisi JG, van Eijk AM, ter Kuile FO, Kolczak MS, Otieno JA, Misore AO, et al. The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya. AIDS 2003; 17:585-594.
32. Yang C, Dash BC, Simon F, van der Groen G, Pieniazek D, Gao F, Hahn BH, Lal RB. Detection of diverse variants of HIV-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees using generic pol and env primer pairs. J Infect Dis 2000; 181:1791-1795.
33. Yang C, Dash B, Hanna SL, Frances HS, Nzilambi N, Colebunders RC, et al. Predominance of subtype G among commercial sex worker from Kinshasa, Democratic Republic of Congo. AIDS Res Hum Retroviruses 2001; 17:361-365.
34. Thompson JD, Higgins DG, Gibson TJ. CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 1994; 22:4673-4680.
35. Felsenstein, J. PHYLIP-phylogeny interference package (version 3.2). Cladistics 1989; 5:164-166.
36. Nkengasong JN, Kalou M, Maurice C, Bile C, Borget MY, Koblavi S, et al. Comparison of Nuclisens and Amplicor Monitor assays for quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in plasma of persons with HIV-1 subtype A infection in Abidjan, Côte d'Ivoire. J Clin Microbiol 1998; 36:2495-2498.
37. Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R. Impact of HIV-1 subtype variation in viral RNA quantitation. AIDS Res Hum Retroviruses 1999; 15:133-142.
38. Emery S, Bodrug S, Richardson BA, Giachetti C, Bott MA, Panteleeff D, et al. Evaluation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000; 38:2688-2695.
39. Overbaugh J, Kreiss J, Poss M, Lewis P, Mostad S, John G, et al. Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya. J Infect Dis 1999; 179 (Suppl. 3):S401-S404.
40. Morison L, Buve A, Zekeng L, Heyndrickx L, Anagonou S, Musonda R, et al. HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS 2001; 15 (Suppl. 4):S109-S116.
41. Wolinsky SM, Wike CM, Korber BT, Hutto C, Parks WP, Rosenblum LL, et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992; 255-1134-1137.
42. Eshleman SH, Becker-Pergola G, Deseyve M, Guay LA, Mracna M, Fleming T, et al. Impact of human immunodeficiency virus type 1 subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV network for prevention trials 012 study). J Infect Dis 2001; 184:914-917.
43. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296:1439-1443.